• 제목/요약/키워드: 2019-nCoV

검색결과 47건 처리시간 0.02초

Small Solitary Ground-Glass Nodule on CT as an Initial Manifestation of Coronavirus Disease 2019 (COVID-19) Pneumonia

  • Tianyi Xia;Jiawei Li;Jiao Gao;Xunhua Xu
    • Korean Journal of Radiology
    • /
    • 제21권5호
    • /
    • pp.545-549
    • /
    • 2020
  • The 2019 novel coronavirus (2019-nCoV) outbreak in Wuhan, Hubei Province, China in 2019 led to large numbers of people being infected and developing atypical pneumonia (coronavirus disease 2019, COVID-19). Typical imaging manifestations of patients infected with 2019-nCoV has been reported, but we encountered an atypical radiological manifestation on baseline computed tomography (CT) images in three patients from Wuhan, China infected with the 2019-nCoV. Surprisingly, the only similar CT finding was a solitary sub-centimeter ground-glass nodule adjacent to bronchovascular bundles, which could be easily overlooked. In addition, the follow-up images in these patients showed how COVID-19 pneumonia evolved from these small nodules. The radiologic manifestation of the three cases will expand contemporary understanding of COVID-19.

코로나바이러스: 사스, 메르스 그리고 코비드-19 (Coronaviruses: SARS, MERS and COVID-19)

  • 김은중;이동섭
    • 대한임상검사과학회지
    • /
    • 제52권4호
    • /
    • pp.297-309
    • /
    • 2020
  • 코로나바이러스는 본래 자연동물숙주에 한정된 엔주틱 감염으로 발견되었으나, 이후 일부 종들은 동물-인간 종의 장벽을 넘어 인간에게 주노틱 감염을 확립하기 위해 진행되었다. 이에 따라 이종 간 장벽의 점프로 인해 사스-코로나바이러스, 메르스-코로나바이러스 그리고 사스- 코로나바이러스2 등의 치명적인 인간 바이러스로 나타났다. 코로나바이러스에는 스파이크, 막, 외피 그리고 뉴클레오캡시드 단백질의 4가지 주요 단백질이 함유되어 있다. 코로나바이러스의 복제 주기는 세포 이입, 게놈 번역, 복제, 조립 그리고 방출로 이어진다. 이들은 2002년 중국 광동성 사스-코로나바이러스가 발병하기 전까지 인간에게 고병원성으로 여겨지지 않았다. 그러나 2002년 중증 급성 호흡기 증후군이 세계적으로 8,422명이 발병하고, 치사율이 11%에 이르는 유행병으로 발생했다. 메르스 코로나바이러스는 낙타 코로나바이러스와 연관성이 높다. 2019년 12월 중국 우한에서 발생한 발병으로 2019-nCoV에 감염된 환자의 군집이 확인되었으며, 곧 전 세계로 확산되었다. 2019-nCoV는 호흡기를 통해 전파된 후 심할 경우 폐렴도 유발할 수 있다. 이 바이러스의 확인에는 감염자의 상기호흡기 표본 검체에 기초한 분자진단법이 사용되었다. 이 리뷰에서는 우리는 바이러스의 구조와 유전적 구성뿐 아니라 생명주기, 진단과 잠재적 치료법을 검토하였다.

A Comprehensive Study of SARS-CoV-2: From 2019-nCoV to COVID-19 Outbreak

  • Waris, Abdul;Ali, Muhammad;Khan, Atta Ullah;Ali, Asmat;Baset, Abdul
    • 한국미생물·생명공학회지
    • /
    • 제48권3호
    • /
    • pp.252-266
    • /
    • 2020
  • The coronavirus disease 2019 (COVID-19) is a highly contagious pneumonia that has spread throughout the world. It is caused by a novel, single stranded RNA virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Genetic analysis revealed that, phylogenetically, the SARS-CoV-2 is related to severe acute respiratory syndrome-like viruses seen in bats. Because of this, bats are considered as a possible primary reservoir. The World Health Organization has declared the COVID-19 outbreak as a pandemic. As of May 27, 2020, more than 5,406,282 confirmed cases, and 343,562 confirmed deaths have been reported worldwide. Currently, there are no approved vaccines or antiviral drugs available against COVID-19. Newly developed vaccines are in the first stage of clinical trials, and it may take a few months to a few years for their commercialization. At present, remdesivir and chloroquine are the promising drugs for treating COVID-19 patients. In this review, we summarize the diversity, genetic variations, primary reservoirs, epidemiology, clinical manifestations, pathogenesis, diagnosis, treatment strategies, and future prospects with respect to controlling the spread of COVID-19.

SARS-CoV-2 Antibody Neutralization Assay Platforms Based on Epitopes Sources: Live Virus, Pseudovirus, and Recombinant S Glycoprotein RBD

  • Endah Puji Septisetyani;Pekik Wiji Prasetyaningrum;Khairul Anam;Adi Santoso
    • IMMUNE NETWORK
    • /
    • 제21권6호
    • /
    • pp.39.1-39.18
    • /
    • 2021
  • The high virulent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus that emerged in China at the end of 2019 has generated novel coronavirus disease, coronavirus disease 2019 (COVID-19), causing a pandemic worldwide. Every country has made great efforts to struggle against SARS-CoV-2 infection, including massive vaccination, immunological patients' surveillance, and the utilization of convalescence plasma for COVID-19 therapy. These efforts are associated with the attempts to increase the titers of SARS-CoV-2 neutralizing Abs (nAbs) generated either after infection or vaccination that represent the body's immune status. As there is no standard therapy for COVID-19 yet, virus eradication will mainly depend on these nAbs contents in the body. Therefore, serological nAbs neutralization assays become a requirement for researchers and clinicians to measure nAbs titers. Different platforms have been developed to evaluate nAbs titers utilizing various epitopes sources, including neutralization assays based on the live virus, pseudovirus, and neutralization assays utilizing recombinant SARS-CoV-2 S glycoprotein receptor binding site, receptor-binding domain. As a standard neutralization assay, the plaque reduction neutralization test (PRNT) requires isolation and propagation of live pathogenic SARS-CoV-2 virus conducted in a BSL-3 containment. Hence, other surrogate neutralization assays relevant to the PRNT play important alternatives that offer better safety besides facilitating high throughput analyses. This review discusses the current neutralization assay platforms used to evaluate nAbs, their techniques, advantages, and limitations.

Being a front-line dentist during the Covid-19 pandemic: a literature review

  • Fallahi, Hamid Reza;Keyhan, Seied Omid;Zandian, Dana;Kim, Seong-Gon;Cheshmi, Behzad
    • Maxillofacial Plastic and Reconstructive Surgery
    • /
    • 제42권
    • /
    • pp.12.1-12.9
    • /
    • 2020
  • Coronavirus is an enveloped virus with positive-sense single-stranded RNA. Coronavirus infection in humans mainly affects the upper respiratory tract and to a lesser extent the gastrointestinal tract. Clinical symptoms of coronavirus infections can range from relatively mild (similar to the common cold) to severe (bronchitis, pneumonia, and renal involvement). The disease caused by the 2019 novel coronavirus (2019-nCoV) was called Covid-19 by the World Health Organization in February 2020. Face-to-face communication and consistent exposure to body fluids such as blood and saliva predispose dental care workers at serious risk for 2019-nCoV infection. As demonstrated by the recent coronavirus outbreak, information is not enough. During dental practice, blood and saliva can be scattered. Accordingly, dental practice can be a potential risk for dental staff, and there is a high risk of cross-infection. This article addresses all information collected to date on the virus, in accordance with the guidelines of international health care institutions, and provides a comprehensive protocol for managing possible exposure to patients or those suspected of having coronavirus.

2019 Novel Coronavirus (COVID-19) Pneumonia: Serial Computed Tomography Findings

  • Jiangping Wei;Huaxiang Xu;Jingliang Xiong;Qinglin Shen;Bing Fan;Chenglong Ye;Wentao Dong;Fangfang Hu
    • Korean Journal of Radiology
    • /
    • 제21권4호
    • /
    • pp.501-504
    • /
    • 2020
  • From December 2019, Coronavirus disease 2019 (COVID-19) pneumonia (formerly known as the 2019 novel Coronavirus [2019-nCoV]) broke out in Wuhan, China. In this study, we present serial CT findings in a 40-year-old female patient with COVID-19 pneumonia who presented with the symptoms of fever, chest tightness, and fatigue. She was diagnosed with COVID-19 infection confirmed by real-time reverse-transcriptase-polymerase chain reaction. CT showed rapidly progressing peripheral consolidations and ground-glass opacities in both lungs. After treatment, the lesions were shown to be almost absorbed leaving the fibrous lesions.

SARS-CoV-2 Delta (B.1.617.2) Variant: A Unique T478K Mutation in Receptor Binding Motif (RBM) of Spike Gene

  • Hyunjhung Jhun;Ho-Young Park;Yasmin Hisham;Chang-Seon Song;Soohyun Kim
    • IMMUNE NETWORK
    • /
    • 제21권5호
    • /
    • pp.32.1-32.14
    • /
    • 2021
  • Over two hundred twenty-eight million cases of coronavirus disease 2019 (COVID-19) in the world have been reported until the 21st of September 2021 after the first rise in December 2019. The virus caused the disease called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Over 4 million deaths blame COVID-19 during the last one year and 8 months in the world. Currently, four SARS-CoV-2 variants of concern are mainly focused by pandemic studies with limited experiments to translate the infectivity and pathogenicity of each variant. The SARS-CoV-2 α, β, γ, and δ variant of concern was originated from United Kingdom, South Africa, Brazil/Japan, and India, respectively. The classification of SARS-CoV-2 variant is based on the mutation in spike (S) gene on the envelop of SARS-CoV-2. This review describes four SARS-CoV-2 α, β, γ, and δ variants of concern including SARS-CoV-2 ε, ζ, η, ι, κ, and B.1.617.3 variants of interest and alert. Recently, SARS-CoV-2 δ variant prevails over different countries that have 3 unique mutation sites: E156del/R158G in the N-terminal domain and T478K in a crucial receptor binding domain. A particular mutation in the functional domain of the S gene is probably associated with the infectivity and pathogenesis of the SARS-CoV-2 variant.

Electrical Leakage Levels Estimated from Luminescence and Photovoltaic Properties under Photoexcitation for GaN-based Light-emitting Diodes

  • Kim, Jongseok;Kim, HyungTae;Kim, Seungtaek;Choi, Won-Jin;Jung, Hyundon
    • Current Optics and Photonics
    • /
    • 제3권6호
    • /
    • pp.516-521
    • /
    • 2019
  • The electrical leakage levels of GaN-based light-emitting diodes (LEDs) containing leakage paths are estimated using photoluminescence (PL) and photovoltaic properties under photoexcitation conditions. The PL intensity and open-circuit voltage (VOC) decrease because of carrier leakages depending on photoexcitation conditions when compared with reference values for typical LED chips without leakage paths. Changes of photovoltage-photocurrent characteristics and PL intensity due to carrier leakage are employed to assess the leakage current levels of LEDs with leakage paths. The current corresponding to the reduced VOC of an LED with leakage from the photovoltaic curve of a reference LED without leakage is matched with the leakage current calculated using the PL intensity reduction ratio and short-circuit current of the LED with leakage. The current needed to increase the voltage for an LED with a leakage under photoexcitation from VOC of the LED up to VOC of a reference LED without a leakage is identical to the additional current needed for optical turn-on of the LED with a leakage. The leakage current level estimated using the PL and photovoltaic properties under photoexcitation is consistent with the leakage level measured from the voltage-current characteristic obtained under current injection conditions.

Druggability for COVID-19: in silico discovery of potential drug compounds against nucleocapsid (N) protein of SARS-CoV-2

  • Ray, Manisha;Sarkar, Saurav;Rath, Surya Narayan
    • Genomics & Informatics
    • /
    • 제18권4호
    • /
    • pp.43.1-43.13
    • /
    • 2020
  • The coronavirus disease 2019 is a contagious disease and had caused havoc throughout the world by creating widespread mortality and morbidity. The unavailability of vaccines and proper antiviral drugs encourages the researchers to identify potential antiviral drugs to be used against the virus. The presence of RNA binding domain in the nucleocapsid (N) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could be a potential drug target, which serves multiple critical functions during the viral life cycle, especially the viral replication. Since vaccine development might take some time, the identification of a drug compound targeting viral replication might offer a solution for treatment. The study analyzed the phylogenetic relationship of N protein sequence divergence with other 49 coronavirus species and also identified the conserved regions according to protein families through conserved domain search. Good structural binding affinities of a few natural and/or synthetic phytocompounds or drugs against N protein were determined using the molecular docking approaches. The analyzed compounds presented the higher numbers of hydrogen bonds of selected chemicals supporting the drug-ability of these compounds. Among them, the established antiviral drug glycyrrhizic acid and the phytochemical theaflavin can be considered as possible drug compounds against target N protein of SARS-CoV-2 as they showed lower binding affinities. The findings of this study might lead to the development of a drug for the SARS-CoV-2 mediated disease and offer solution to treatment of SARS-CoV-2 infection.

Study on (n,p) reactions of 58,60,61,62,64Ni using new developed empirical formulas

  • Yigit, Mustafa
    • Nuclear Engineering and Technology
    • /
    • 제52권4호
    • /
    • pp.791-796
    • /
    • 2020
  • Nuclear fusion seems to be a good choice of energy source in the future. Nickel is one of the crucial structural materials for fusion devices. In this work, the cross section data of 58Ni(n,p)58Co, 60Ni(n,p)60Co, 61Ni(n,p)61Co, 62Ni(n,p)62Co and 64Ni(n,p)64Co reactions were calculated using the nuclear codes ALICE/ASH, EMPIRE 3.2 and TALYS 1.8. In addition, the cross sections were calculated with the empirical formulas obtained in our previous paper at 14-15 MeV. The obtained results were compared with the measured values in the literature, and with the evaluated data files (JEFF-3.3, TENDL-2017, ENDF/B-VIII.0).